Sequential immunization induces strong and broad immunity against all four dengue virus serotypes.
A major challenge in dengue vaccine development is the need to induce immunity against four dengue (DENV) serotypes. Dengvaxia®, the only licensed dengue vaccine, consists of four variant dengue antigens, one for each serotype. Three doses of immunization with the tetravalent vaccine induced only su...
| मुख्य लेखकों: | , , , , , |
|---|---|
| स्वरूप: | लेख |
| भाषा: | English |
| प्रकाशित: |
2021
|
| ऑनलाइन पहुंच: | https://hdl.handle.net/1721.1/135275 |